Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"
ACS Med Chem Lett
.
2019 Aug 6;10(9):1357.
doi: 10.1021/acsmedchemlett.9b00316.
eCollection 2019 Sep 12.
Authors
Angela De Simone
,
Valeria La Pietra
,
Nibal Betari
,
Nicola Petragnani
,
Mariarosaria Conte
,
Simona Daniele
,
Deborah Pietrobono
,
Claudia Martini
,
Sabrina Petralla
,
Raffaella Casadei
,
Lara Davani
,
Flavia Frabetti
,
Pasquale Russomanno
,
Ettore Novellino
,
Serena Montanari
,
Vincenzo Tumiatti
,
Patrizia Ballerini
,
Federica Sarno
,
Angela Nebbioso
,
Lucia Altucci
,
Barbara Monti
,
Vincenza Andrisano
,
Andrea Milelli
PMID:
31531210
PMCID:
PMC6746190
DOI:
10.1021/acsmedchemlett.9b00316
Abstract
[This corrects the article DOI: 10.1021/acsmedchemlett.8b00507.].
Publication types
Published Erratum